In their war against e-cigarettes, government officials often claim that the devices are a gateway to smoking. CDC director Dr. Tom Frieden asserted (here) that “…many kids are starting out with e-cigarettes and then going on to smoke conventional cigarettes.” The National Cancer Institute last March promoted (here) Dr. Stanton Glantz’s tortured analysis of youth e-cigarette use (discussed here and here). While his data failed to support a gateway effect, his employer, the University of California San Francisco, made the claim anyway (here).
Ebola has proven that it is a disease without borders and many people would like some assurance that the US health care system has this under control. Instead we’re busy playing the “blame game.”
In order to limit our exposure to a possible epidemic, non-essential travel to and from the afflicted regions be curtailed. There should be no casual travel or immigration. Contrary to the administration’s talking points, this has no effect on humanitarian aid, any more than our current ban on travel for political reasons.
Rates of smoking and use of other tobacco products among teens are so low that they no longer provide a valid basis for the draconian anti-tobacco policy prescriptions favored by the FDA and CDC.
Breaking news as this article was being written is that Howard University hospital in Washington, D.C. has admitted a patient — a recent traveler to Nigeria — who has symptoms that could be associated with Ebola. Receiving little coverage was a report on Thursday, 3rd, that an American freelance television cameraman working for NBC News in Liberia has contracted Ebola, the fifth U.S. citizen known to be infected with the deadly virus.
The New England Journal of Medicine and authors of a commentary on e-cigarette use have ignored our call for correction of a substantial error regarding e-cigarette use among American schoolchildren in 2011 and 2012. Authors Amy L. Fairchild, Ronald Bayer and James Colgrove of Columbia University double-counted some users in a figure they used to illustrate data from the National Youth Tobacco Survey (NYTS).
The Heartland Institute has been diligently following the Advisory Committee on Immunization Practice’s (ACIP) decision on whether to recommend meningitis vaccination for infants. With three different meningitis vaccines under consideration,[…]
In the most recent GOP debate, Gov. Rick Perry and Rep. Michelle Bachmann tussled over the particulars of Perry requiring Human Papillomavirus (HPV) vaccinations. Though he now admits it a[…]
Heartland’s Kendall Antikeier mentioned our efforts to bring the public’s attention to the Centers for Disease Control’s seeming reluctance to recommend — after the FDA has done so — a[…]
Upon first knowledge that the Center for Disease Control (CDC) was debating whether to recommend an infant meningitis vaccine due to “cost-effectiveness,” The Heartland Institute has been actively following the[…]
As the US Center for Disease Control (CDC) debates whether to recommend the FDA-approved infant meningitis vaccine, Canada is enduring a similar struggle. Cost-effective analysis by government bureaucrats is keeping[…]
Heartland releases new Infant Meningitis Vaccine Policy Tip Sheet! Today in Shoreline, Washington, the Centers for Disease Control and Prevention (CDC), its Advisory Committee on Immunization Practices (ACIP), and The[…]
Vaccination has been found to be one of the most cost-effective health-care choices. Historically, if a vaccination was approved by the Food and Drug Administration (FDA), the Centers for Disease[…]